Stay updated on Palovarotene for MO: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.

Latest updates to the Palovarotene for MO: Efficacy & Safety Clinical Trial page
- Check5 days agoChange DetectedAdded a 'Show glossary' option and updated footer labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' including capitalization adjustments. Updated the revision tag from 'Revision: v3.3.4' to 'Revision: v3.4.0'.SummaryDifference0.2%

- Check12 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. This appears to be a minor maintenance update with no visible impact on study content or functionality.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedNo additions or deletions were observed on the Study Details page for NCT03442985. The page content remains focused on study overview, design, eligibility, and outcome measures.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded multiple location entries (California, District of Columbia, Ontario, Osaka, North Holland, etc.) and removed several existing locations, with a new revision tag v3.3.3.SummaryDifference2%

- Check48 days agoChange DetectedNo significant changes detected on the Study Details page; the content and layout remain focused on palovarotene MO trial details, eligibility criteria, interventions, and locations.SummaryDifference0.1%

- Check63 days agoChange Detected- Revision label updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Palovarotene for MO: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.